Wound Management Market Segments Growing at Rates of Up to 17% Annually in Key Product and Regional Market Areas, According to New Report from MedMarket Diligence, LLC
Globally, the market for the diverse array of products in surgical, chronic and acute wound management stands at $13 billion, with aggregate growth at 7% annually. Select product and geographic sectors are demonstrating appreciably stronger growth. The global market for wound management is analyzed in a new MedMarket Diligence report.
(PRWEB) August 8, 2005 -- Globally, the market for the diverse array of
products in surgical, chronic and acute wound management stands at $13 billion,
with aggregate growth at 7% annually. Select sectors are demonstrating
appreciably stronger growth including active physical stimulation,
pharmaceuticals, enzymatic debriders, tissue engineering, and other active
therapies for wound management. Differences geographically in the clinical
management of wounds and in the adoption of new products are also creating
opportunities in local markets. These data are detailed in the August 2005
report by MedMarket Diligence on the worldwide wound management
market.
Products in the "advanced" segment of wound care, encompassing
drugs, physical stimulation devices, enzymatic debridement, tissue engineered
skin substitutes and others, represent areas of the greatest market growth in
this arena. These technologies have emerged, generally, over the last twenty
five years since the introduction of the "moist healing" concept and the
aggressive development by big medical device companies seeking new innovations
in an increasingly competitive environment full of generic manufacturers and
distributors of advanced wound management products.
The 2005 MedMarket
Diligence report on wound management details the current and emerging
technologies and products spanning dressings, closure devices, debridement,
pharmacological products, tissue engineered products and others. Detailed
current/historic market size and competitor market shares are given for the
U.S., Japan, Europe (with detail on Germany, France, UK, Italy, and Spain). The
report's outline and description of coverage is detailed at http://www.mediligence.com/rpt-s225.htm.
# # #
Source : http://www.prweb.com/releases/2005/8/prweb270143.htm